Non-Hodgkin's Lymphoma Vs. Hodgkin's Lymphoma
Lymphomas are cancers of the white blood cells called lymphocytes, part of the body's immune system. In lymphoma, the lymphocytes morph into a cancer cell and accumulate in the lymph nodes and lymphatic system, where they crowd out normal lymphocytes. The two main types of lymphomas are Hodgkin's lymphoma and Non-Hodgkin's lymphoma. Hodgkin's and Non-Hodgkin's lymphomas affect different lymphocytes, so the treatment options and the course of the disease may differ.
Cell Types
In Hodgkin's lymphoma, a specific type of cell called a Reed-Sternberg cell is present in the bloodstream and lymph nodes. Reed-Sternberg cells, named after the scientists who discovered them, are large cells with two nuclei easily visible under a microscope. Non-Hodgkin's lymphoma does not contain these cells, but can have a variety of different cancer cells that have different characteristics, depending on the specific subtype of non-Hodgkin's lymphoma.
Epidemiology
What Are the Differences Between Multiple Myeloma & Myeloid Leukemia?
Learn More
According to the Leukemia and Lymphoma Society, in 2009, approximately 148,460 people were living with Hodgkin's lymphoma in the U.S. and approximately 452,720 people had non-Hodgkin's lymphoma. The incidence of Hodgkin lymphoma is higher in males, while non-Hodgkin's lymphoma occurs more often in females.
Causes
The exact causes of both Hodgkin's and non-Hodgkin's lymphoma are still undetermined, but some associations and risk factors may be involved, including infection with HIV, mononucleosis or human T-cell lymphocytotropic virus. An inherited susceptibility also is possible because family clustering is occasionally seen. Infections associated with non-Hodgkin's lymphoma include Epstein-Barr virus, HIV, human T-lymphotropic virus and Helicobacter pylori.
Clinical Features and Diagnosis
How Does Lymphoma Cancer Spread?
Learn More
Aside from the presence of Reed-Sternberg cells in Hodgkin's lymphoma., other clinical signs differ between the two types. Hodgkin's lymphoma tends to be confined to only one lymph node in the body and spreads to the bloodstream from there, while in Non-Hodgkin's lymphoma, the cancer occurs in many different lymph nodes, according to the Merck Manuals. Hodgkin's lymphoma also spreads in a more organized fashion than Non-Hodgkin's lymphoma does and does not often involve other areas of the body. Thus, Hodgkin's lymphoma often is easier to treat than Non-Hodgkin's lymphoma.
- Aside from the presence of Reed-Sternberg cells in Hodgkin's lymphoma., Hodgkin's lymphoma also spreads in a more organized fashion than Non-Hodgkin's lymphoma does and does not often involve other areas of the body.
Treatment
Treatment of lymphoma depends not only on the type, but also on the stage of the disease when it is discovered. Radiation and chemotherapy are used to treat both types, but chemotherapy is the primary treatment option for non-Hodgkin's lymphoma, according to the Nemours Foundation. Hodgkin's lymphoma patients may also be treated with surgery or hematopoietic stem cell transplantation. Non-Hodgkin's lymphoma patients may be treated with both chemotherapy and radiation instead of just one of the two treatments. They may also receive treatment with anti-CD20 monoclonal antibodies or hematopoietic stem cell transplantation.
- Treatment of lymphoma depends not only on the type, but also on the stage of the disease when it is discovered.
- Non-Hodgkin's lymphoma patients may be treated with both chemotherapy and radiation instead of just one of the two treatments.
Related Articles
References
- Lymphoma Research Foundation: About Lymphoma
- Merck Manuals: Lymphomas
- Nemours Foundation Kids Health: Childhood Cancers--Lymphoma
- Leukemia and Lymphoma Society: Lymphoma
- Maggioncalda A, Malik N, Shenoy P, et al. Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma. Adv Hematol. 2011;2011;736261. doi:10.1155/2011/736261
- Horesh N, Horowitz NA. Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy. Rambam Maimonides Med J. 2014 Oct;5(4):e0038. doi:10.5041/RMMJ.10172
- Klimm B, Franklin J, Stein H, et al. Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J Clln Oncol. 2011 Oct;29(29):3914-20. doi:10.1200/JCO.2011.36.4703
- Brücher BLDM, Jamall IS. Somatic Mutation Theory: Why it's Wrong for Most Cancers. Cell Physiol Biochem. 2016;38:1663-80. doi:10.1159/000443106
- Freedman AS, Jacobson CA, Mauch P, Aster JC. Chapter 103: Non-Hodgkin’s lymphoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology (10th ed). Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2015.
- Ewers EC, Sheffler RL, Wang J, Ngauy V. Immunoproliferative Small Intestinal Disease Associated with Overwhelming Polymicrobial Gastrointestinal Infection with Transformation to Diffuse Large B-cell Lymphoma. Am J Trop Med Hyg. 2016 May;94(5):1177-81. doi:10.4269/ajtmh.15-0831
- Anderson LA, Atman AA, McShane CM, et al. Common infection-related conditions and risk of lymphoid malignancies in older individuals. Br J Cancer. 2014 May 27;110(11):2796-803. doi:10.1038/bjc.2014.173
- Vockerodt M, Cader FZ, Shannon-Lowe C, Murray P. Epstein-Barr virus and the origin of Hodgkin lymphoma. Chin J Cancer. 2014 Dec;33(12):591-7. doi:10.5732/cjc.014.10193
- Floch P, Mégraud F, Lehours P. Helicobacter pylori Strains and Gastric MALT Lymphoma. Toxins (Basel). 2017 Apr;9(4):132. doi:10.3390/toxins9040132
- Pozzato G, Mazzaro C, Dal Maso L. Hepatitis C virus and non-Hodgkin’s lymphomas: Meta-analysis of epidemiology data and therapy options. World J Hepatol. 2016 Jan;8(2):107-16. doi:10.4254/wjh.v8.i2.107
- Narkhede M, Arora Sh, Ujjani C. Primary effusion lymphoma: current perspective. Onco Targets Ther. 2018;11:3747-54. doi:10.2147/OTT.S167392
- Mehta-Shah N, Ratner L, Horwitz SM. Adult T-Cell Leukemia/Lymphoma. J Oncol Prac. 2017 Aug;13(8):487-92. doi:10.1200/JOP.2017.021907
- Kim CJ, Friedman DM, Curtis RE, et al. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers. Leuk Lymphoma. 2013 Aug; 54(8). doi:10.3109/10428194.2012.753543
- Bertrand A, Giovannucci E, Rosner BA, et al. Dietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts. Am J Clin Nutrition. 2017 Aug;106(2):650-6. doi:10.3945/ajcn.117.155010
- Ghione P, Cordeiro PG,Ni A, Hu Q. Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants. J Clin Oncol. 2019 May;37(Suppl 15):1565. doi:10.1200/JCO.2019.37.15_suppl.1565
- Clemens MW, Horowitz SM. NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Large Cell Lymphoma. Aesthetic Surg J. 2017;37(3):285-9. doi:10.1093/asj/sjw259
- Cerhan JR, Slager SL. Familial predisposition and genetic risk factors for lymphoma. Blood. 2015 Nov;126(20):2265-73. doi:10.1182/blood-2015-04-537498
- Navaranjan G, Hohenadel K, Blair A, et al. Exposures to multiple pesticides and the risk of Hodgkin lymphoma in Canadian men. Cancer Causes Control. 2013;24(9):1661-73. doi:10.1007/s10552-013-0240-y
- Scholz M, Engert A, Franklin J, et al. Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL: Experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Ann Oncol. 2011 Mar;22(3):681-8. doi:10.1093/annonc/mdq408
- Smedby KE, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029-4038. doi:10.1182/blood-2007-10-119974
- Spinelli JJ, Ng CH, Weber JP, et al. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer. 2007 Dec 15;121(12):2767-75. doi:10.1002/ijc.23005
- Strongman H, Brown A, Smeeth L, Bhaskaran K. Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals. Br J Cancer. 2019;120:768-70. doi:10.1038/s41416-019-0401-1
Writer Bio
Bridget Coila specializes in health, nutrition, pregnancy, pet and parenting topics. Her articles have appeared in Oxygen, American Fitness and on various websites. Coila has a Bachelor of Science in cell and molecular biology from the University of Cincinnati and more than 10 years of medical research experience.